MentionFox
Home › Executive changes › agilon health, inc.
Leadership changes · AGL · SEC Form 8-K, Item 5.02

Leadership changes at agilon health, inc. (2026)

Before you join, sell to or invest in agilon health, inc.

MentionFox check on agilon health, inc.: no red flags found in 3 sources (checked 14 November 2026). mentionfox.com/c/executive-changes/agilon-health

Check agilon health, inc. before you join, sell or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about agilon health, inc.?

Who joined and who left agilon health, inc. (AGL)? 3 filings reported from 2026-01-07 to 2026-07-22, each cited to the company's own filing.

As of November 14, 2026, agilon health, inc. has reported 3 leadership change filings to the SEC under Item 5.02 of Form 8-K, from January 7, 2026 to July 22, 2026 (Form 8-K, July 22, 2026).

29 companies changed executives this week, 1 had other signals.

Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.

ONITY GROUP INC.announced the departure of its Chief Investment Officer
Adicet Bio, Inc.announced the departure of its Director
MAMMOTH ENERGY SERVICES, INC.announced the departure of its Chief Operating Officer
CERENOME, INC.named a new Director
Cohen & Co Inc.named a new Chief Executive Officer
Check one company free All companies that changed executives this week

North Peak Capital Management, LLC also filed stake reports on 2 other companies ↓

Sell to companies like agilon health, inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Key facts

  • · In / out: Reported · Person: not named in the filing · 8-K, 2026-07-22
  • · In / out: Reported · Person: not named in the filing · 8-K, 2026-04-27
  • · In / out: Reported · Person: not named in the filing · 8-K, 2026-01-07
Changes3
Latest filing2026-07-22

agilon health, inc. reported changes in 3 filings among its directors and officers to the SEC on Form 8-K, Item 5.02, from 2026-01-07 to 2026-07-22. Every row below is cited to the filing it comes from, and this page adds each new change as agilon health, inc. files it.

Also on the record for agilon health, inc.

DateRecordFigureOur pageSource
August 12, 2026Stake report, Schedule 13G/A, by AQR Capital Management, LLC4.15% of the class5%+ stakesSource
August 11, 2026Stake report, Schedule 13G/A, by THE GOLDMAN SACHS GROUP, INC.3.9% of the class5%+ stakesSource
May 14, 2026Stake report, Schedule 13G, by AQR Capital Management, LLC5.87% of the class5%+ stakesSource
May 13, 2026Stake report, Schedule 13G, by THE GOLDMAN SACHS GROUP, INC.6.1% of the class5%+ stakesSource
January 30, 2026Stake report, Schedule 13G/A, by The Vanguard Group4.41% of the class5%+ stakesSource
November 13, 2025Stake report, Schedule 13G/A, by North Peak Capital Management, LLC9.5% of the class5%+ stakesSource
November 5, 2025Stake report, Schedule 13G/A, by FMR LLC3.7% of the class5%+ stakesSource
October 30, 2025Stake report, Schedule 13G/A, by The Vanguard Group5.86% of the class5%+ stakesSource
September 5, 2025Stake report, Schedule 13G/A, by Capital World Investors2.6% of the class5%+ stakesSource
August 29, 2025Stake report, Schedule 13G, by North Peak Capital Management, LLC5.2% of the class5%+ stakesSource
August 13, 2025Stake report, Schedule 13G/A, by Capital International Investors2.4% of the class5%+ stakesSource
August 13, 2025Stake report, Schedule 13G/A, by Capital World Investors11% of the class5%+ stakesSource

Selling to them or working with them? See who runs agilon health, inc. now and the warning signs.

Free to see. No signup.

Keep reading

More on agilon health, inc. and the records around it.

agilon health, inc. elsewhere on the record

Companies that share a holder

Want the whole picture on agilon health, inc.?

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on agilon health, inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on agilon health, inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    15 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The newest 12 of 13 records.

Timeline

FiledIn / outPersonRoleEffectiveSource
2026-07-22Reportednot named in the filing8-K, 2026-07-22
2026-04-27Reportednot named in the filing8-K, 2026-04-27
2026-01-07Reportednot named in the filing8-K, 2026-01-07
Selling to agilon health, inc.?

New leaders reset buying decisions — get the Full Report on agilon health, inc.: who runs it, how the money works and what to watch, every claim linked to its source.

Get the Full Report

Watch agilon health, inc.

Hiring for a seat like this?

Find people with the same kind of experience as the senior executive at agilon health, inc., with the record behind each one.

Find candidates like senior executive at agilon health, inc.

Every change, in the filing's words

Filed 2026-07-22 · 8-K

Reported

(the "Company") provided notice to Girish Venkatachaliah, the Company's Chief Technology Officer, that Mr. Venkatachaliah's employment with the Company will terminate effective August 1, 2026 (the "Separation Date").

Also stated in this filing

  • In connection with Mr. Venkatachaliah's separation from employment, the Company provided Mr. Venkatachaliah with a Severance Agreement and General Release (the "Severance Agreement") which will become effective eight days following Mr. Venkatachaliah's execution of the Severance Agreement.
  • Concurrently, the Company and Mr. Venkatachaliah intend to enter into a Consulting Agreement (the "Consulting Agreement") effective as of August 1, 2026 and pursuant to which Mr. Venkatachaliah will provide the Company with transition consulting services through December 31, 2026 for no consideration other than the continued equity award vesting referenced below.
Filed 2026-04-27 · 8-K

Reported

(the "Company") entered into an Employment Agreement (the "Employment Agreement") with Tim O'Rourke, pursuant to which Mr. O'Rourke will serve as the Company's Chief Executive Officer and President, reporting to the Board of Directors (the "Board").

Also stated in this filing

  • Mr. O'Rourke is expected to commence employment with the Company on May 7, 2026 (the "Commencement Date").
  • Effective as of the Commencement Date, the Board has also appointed Mr. O'Rourke to the Board as a Class III director.
  • From May 2021 to June 2025, Mr. O'Rourke, age 54, served as President of Help at Home, LLC, a home care agency providing alternatives to living in a nursing home or long-term care facility.
  • Prior to his time at Help at Home, LLC, Mr. O'Rourke served as Managing Director of Marketplace for Centene Corporation from 2019 to 2020 and Chief Executive Officer of Ascension Complete LLC, a joint venture between Centene Corporation and Ascension Health, from November 2020 to May 2021.
  • From 1996 to 2019, Mr. O'Rourke held several positions at Humana, Inc., including Senior Vice President of the Central Division and President of Provider Development.
  • Mr. O'Rourke received a B.S. in Public Health, Health Administration from Northern Illinois University.
  • As Chief Executive Officer and President, Mr. O'Rourke will be paid a base salary of $850,000 and will be eligible for an annual bonus opportunity equal to 100% of his base salary at target levels of performance.
Filed 2026-01-07 · 8-K

Reported

Mr. Schwaneke will also be entitled to the vesting described in clause (ii) above if he voluntarily terminates employment with the Company more than 18 months after January 1, 2026.

Also stated in this filing

  • Compensatory Arrangements of Certain Officers On December 31, 2025, agilon health, inc.
  • (the "Company") entered into an Amended and Restated Employment Agreement with Jeffrey Schwaneke, the Company's Chief Financial Officer and Executive Vice President (the "Amended Employment Agreement"), effective as of January 1, 2026.
  • The Employment Agreement amends and restates Mr. Schwaneke's prior Employment Agreement with the Company, dated June 3, 2024 and as previously disclosed by the Company (the "Prior Employment Agreement").
  • The Amended Employment Agreement is substantially the same as the Prior Employment Agreement, except as noted below.
  • The Amended Employment Agreement provides for payment of accrued obligations upon termination of Mr. Schwaneke's employment, and also provides for additional severance and/or continued vesting of certain equity awards in specified circumstances.
  • The Company expects to file the Amended Employment Agreement as an exhibit to a future periodic report..

Tools for this story

Each opens in a new tab, filled in for agilon health, inc.. With no account yet, you sign up free and land on the result.

Where this comes from

A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.

Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.

Not for employment, credit or tenancy decisions. MentionFox research is for sales, partnership and investor research. Permitted use

Cite this page

Permanent URL: https://mentionfox.com/executive-changes/agilon-health
Last updated 2026-11-14
Primary record: SEC filing 1 · SEC filing 2 · SEC filing 3 · SEC filing 4
What changed at the top of agilon health, inc.? (2026). MentionFox, 2026-11-14. https://mentionfox.com/executive-changes/agilon-health